AXSM — Axsome Therapeutics Share News
0.000.00%
Last trade - 00:00- $7.51bn
- $7.40bn
- $638.50m
Axsome Therapeutics' ADHD drug meets main goal in late-stage study (updated)
Axsome Therapeutics' ADHD drug meets main goal in late-stage study
U.S. STOCKS ON THE MOVE-Starbucks, Bristol Myers Squibb, Home Depot
U.S. STOCKS ON THE MOVE-BioMarin, Azul, Sun Communities
U.S. STOCKS ON THE MOVE- Twilio, Bath & Body Works, Wingstop
Axsome Therapeutics rises on migraine drug trial data
U.S. RESEARCH ROUNDUP-Axsome Therapeutics, Penumbra, Republic Services
Axsome Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Axsome Therapeutics Q4 Net Income USD -74.912 Million
U.S. STOCKS ON THE MOVE-Nike, WesBanco, Monday.Com
U.S. STOCKS ON THE MOVE-NXP Semiconductors, Oil stocks, Mobileye
U.S. STOCKS ON THE MOVE-Reddit, Rockwell Automation, NXP Semiconductors
Axsome Therapeutics rises on settlement with Teva for depression drug
U.S. RESEARCH ROUNDUP-Abbvie, Comstock Resources, Sherwin-Williams
US FDA approves Axsome Therapeutics' migraine drug (updated)
US FDA approves Axsome Therapeutics' migraine drug
U.S. RESEARCH ROUNDUP- Capital One Financial, Netflix, Regeneron Pharmaceuticals
U.S. RESEARCH ROUNDUP- Axsome Therapeutics, Ducommun, Vacasa
U.S. STOCKS ON THE MOVE-Vivid Seats, Cheniere Energy, U.S. natural gas producers